Astria Therapeutics (ATXS) PT Raised to $26 at Evercore ISI
Tweet
Share
E-mailGet Alerts ATXS Hot Sheet
Price: $12.58 --0%
Rating Summary:
2 Buy, 6 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 4 | Down: 8 | New: 8
Rating Summary:
2 Buy, 6 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 4 | Down: 8 | New: 8
Join SI Premium – FREE
Evercore ISI analyst Gavin Clark-Gartner raised the price target on Astria Therapeutics (NASDAQ: ATXS) to $26.00 (from $25.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Berenberg Downgrades PolyPeptide Group AG (PPGN:SW) to Hold
- AUTO1 Group SE (AG1:GR) (ATOGF) PT Raised to EUR39 at Citi
- Aviva PLC (AV:LN) (AVVIY) PT Raised to GBP820 at Berenberg
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
